Circulation Research. 1995;77:394-406
(Circulation Research. 1995;77:394-406.)
© 1995 American Heart Association, Inc.
23Na and 31P Nuclear Magnetic Resonance Studies of Ischemia-Induced Ventricular Fibrillation
Alterations of Intracellular Na+ and Cellular Energy
M. M. Pike,
C. S. Luo,
S. Yanagida,
G. R. Hageman,
P. G. Anderson
From the Department of Medicine (M.M.P., C.S.L., S.Y.), Division of
Cardiovascular Disease; the Department of Physiology and Biophysics (G.R.H.);
and the Department of Pathology (P.G.A.), Division of Molecular/Cellular
Pathology; University of Alabama at Birmingham.
Correspondence to Dr M.M. Pike, Department of Medicine, Division of Cardiovascular Disease, 703 S 19th Street, ZRB 308, Birmingham, AL 35294-0007.
 |
Abstract
|
|---|
Abstract To clarify the role of
Na
+i, pH
i, and
high-energy phosphate
(HEP) levels in the initiation and
maintenance of ischemia-induced
ventricular
fibrillation (VF), interleaved
23Na and
31P
nuclear
magnetic resonance spectra were collected on perfused rat
hearts
during low-flow ischemia (51 minutes, 1.2 mL/g wet wt).
When
untreated, 50% of the hearts from normal (sham) rats and 89%
of
the hypertrophied hearts from aortic-banded (band) rats
(
P<.01
versus sham) exhibited VF. Phosphocreatine content
was significantly
higher in sham than band hearts during control
perfusion (53.3±1.6
versus 39.8±2.0 µmol/g dry wt). Before VF at 20
minutes
of ischemia, Na
+i accumulation
was greater in hearts that eventually
developed VF than in hearts that
did not develop VF for both
band and sham groups (144% versus 128% of
control in sham;
P<.005)
and was the strongest
metabolic predictor of VF; ATP depletion
was also greater
for VF hearts in the sham group. Infusion of
the
Na
+-H
+ exchange inhibitor
5-(
N,
N-hexamethylene)-amiloride
prevented
VF in sham and band hearts; reduced Na
+i
accumulation
but similar HEP depletion were observed compared with VF
hearts
before the onset of VF. Rapid changes in
Na
+i, pH
i, and HEP
began
with VF, resulting in intracellular Na
+i
overload (

300% of control)
and increased HEP depletion. A delayed
postischemic functional
recovery occurred in VF hearts,
which correlated temporally
with the recovery of
Na
+i. In conclusion, alterations in
Na
+i were associated with spontaneous VF
transitions, consistent
with involvement of excess
Na
+i accumulation in VF initiation
and
maintenance and with previously reported alterations in
Ca
2+i with VF. Hypertrophied band hearts
exhibited enhanced susceptibility
to ischemia-induced VF,
possibly linked to a lower HEP reserve.
Key Words: ventricular fibrillation intracellular Na+ ischemia nuclear magnetic resonance cardiac hypertrophy
 |
Introduction
|
|---|
Ventricular fibrillation (VF) is a lethal
arrhythmia characterized
by rapid unsynchronized
depolarizations, resulting in ineffective
contractile activity. It is
often associated with myocardial
infarction, heart failure, or
myocardial reperfusion. Hypertrophied
myocardium may have
enhanced susceptibility to VF initiation.
1 2 3 4 An
understanding of the cellular basis of this life-threatening
arrhythmia,
in terms of both initiation and
maintenance, is critical in
terms of potential strategies for
prevention or treatment. Nevertheless,
the mechanisms underlying VF are
still controversial. The classic
mechanisms involve reentrant
excitation, which is caused by
areas of altered action potential
conduction. However, various
reports have indicated that the initiation
and maintenance of
VF could also be related to
membrane-triggered activity activated
by elevated cytosolic
free Ca
2+
(Ca
2+i).
5 6 7 8 9 10 11 12 13 Direct
measurements of Ca
2+i using the
19F NMR indicator 5F-BAPTA,
14 the
fluorescent indicator indo 1,
15 and the
bioluminescent
indicator aequorin
16 have revealed rapid
Ca
2+i increases on
electrically induced
VF in perfused hearts. Aequorin measurements
have also indicated
Ca
2+i increases preceding VF in
perfused
ferret hearts exposed to acetylstrophanthidin
16 ;
these increases
were followed by larger increases during VF. In a
multicellular
myocyte model, fura 2 measurements of
Ca
2+i have indicated that
Ca
2+i elevations preceded the
development of arrhythmias and progressed
further with
induction of chaotic beating activity.
13 These
studies
provide evidence for a role for Ca
2+i
overload in the
metabolic changes leading
to
13 16 and sustaining
13 14 15 16 VF. Energy
supply/demand imbalance can be impaired during VF,
as indicated by
increased oxygen consumption, lactate production,
and ATP
depletion as well as, in some cases, reduced functional
recovery.
14 17 18 However, to understand VF as it normally
occurs in vivo,
metabolic measurements investigating VF
during a physiological
model of ischemia
are required. By use of NMR spectroscopy and
other techniques, various
studies have reported increases in
Ca
2+i and/or
Na
+i during myocardial
ischemia
19 20 21 22 23 24 25 26 27 and are generally consistent
with the hypothesis that there
is substantial coupling between the
Na
+i and Ca
2+i
levels during
ischemia/reperfusion via
Na
+-Ca
2+ exchange.
28 29
However, most
of these measurements have been performed with the global
zero-flow
ischemia model, which decreases excitability
sufficiently to
prevent VF. In the present study, we have used a
low-flow ischemia
model. The study used the
23Na
NMR shift reagent Tm(DOTP)
5- to resolve the intracellular
and extracellular
23Na NMR signals.
30 This
reagent enables excellent resolution of the
Na
+i resonance
in perfused tissues and has the
added benefit of allowing acquisition
of excellent
31P NMR
spectra as well. We have made use of this
advantage by acquiring
rapidly interleaved
23Na and
31P NMR
spectra,
continuously monitoring Na
+i,
pH
i, and high-energy
phosphate levels in the same
preparation.
23 The goal was to
determine whether
alterations in these parameters are associated
with the
initiation and/or maintenance of VF during ischemia.
The
hypothesis that excess Na
+i accumulation is
associated with,
or required for, VF induction during ischemia
was tested by
inhibition of a major Na
+ influx pathway,
Na
+-H
+ exchange. The
relative
susceptibility of normal and hypertrophied myocardium
to VF
was assessed under controlled ischemic conditions. The
studies
have provided new information concerning the relation
between
Na
+i, cellular energy levels, and
ischemia-induced VF.
 |
Materials and Methods
|
|---|
Heart Preparations
A total of 57 perfused hearts were included in the present
study:
51 were used for NMR and biochemical measurements, and 6 were
used
for electrophysiological measurements. Both
normal (sham, n=30)
and aortic-banded (band, n=27) male
Sprague-Dawley rats were
used. Band rats were surgically
banded between the innominate
and left subclavian arteries at 3 weeks
of age; aortic blood
flow was restricted progressively with animal
growth. Sham rats
were subjected to the same anesthesia
(Brevital, 5 mg IP) and
surgery excepting band placement. All animals
were killed at
8 weeks of age. The rats were heparinized (2000 U/kg
IP), anesthetized
with pentobarbital (60 mg/kg IP), and
weighed. The hearts were
removed, put in cold perfusate, and quickly
trimmed, weighed,
and Langendorff-perfused. The right atrium was
removed, and
atrioventricular conduction was surgically
blocked. All hearts
were stimulated at 150 beats per minute throughout
the experiments
by using a stimulator connected to the right ventricle
via polyethylene
tubing filled with KCl-saturated agar and tipped with
thin platinum
wires. The hearts were initially perfused at 80 mm Hg by
using
a previously described perfusion system
23 consisting
of a modified
Krebs-Henseleit perfusate aerated with 95%
O
2/5% CO
2 (32°C,
pH adjusted to 7.4
with NaOH) and containing the following (mmol/L):
NaCl 112,
NaHCO
3 24, KCl 4.7, MgSO
4 1.2, glucose 11,
pyruvate
5, CaCl
2 1.5, and EDTA 0.5 (Sigma Chemical Co).
Hearts were
then switched to the shift reagent perfusate, and
coronary flow
was then pump-controlled and adjusted to a
constant rate of
12 mL/g wet wt. The shift reagent perfusate was
identical to
that described above, except for the inclusion of 4 mmol/L
of
the
23Na NMR shift reagent Na
5Tm(DOTP); NaCl
was adjusted to
keep the total Na
+ content unchanged, and
total Ca
2+ content
was adjusted to 5.5 mmol/L to
adjust for binding by the shift
reagent, resulting in a free ionized
Ca
2+ of 1.07 mmol/L as
measured by using a
Ca
2+ ionselective electrode (Orion)
and perfusate
(32°C, 95% O
2/5% CO
2) calibration
solutions
(excluding shift reagent or EDTA). Tm(DOTP)
5-
was synthesized,
purified, and recovered after the experiment, as
described previously.
23 All perfusate was filtered through
5-µm filters before
the experiment and with in-line filters during
the experiment.
Heart function was monitored with a fluid-filled left
ventricular
balloon in line with a Spectramed p23XL
transducer and an Astro-Med
MT9500 multichannel recorder. Left
ventricular end-diastolic
pressure was set at 4
to 5 mm Hg. The functional data were recorded
both on paper and
digitally. NMR spectra were acquired continuously
during a control
period, 51 minutes of 10% low-flow ischemia
(1.2 mL/g wet wt),
and 60 minutes of reperfusion at the control
flow rate. After the
experiment, all hearts were weighed after
drying to a constant weight
at 80°C. All procedures involving
animals conformed to University of
Alabama at Birmingham Institutional
Animal Care and Use Committee
guidelines.
Pharmacological Interventions
The Na+-H+ exchange
inhibitor HMA was dissolved in perfusate (617 µmol/L
stock) and infused into the aortic line just above the heart (final
concentration, 10 µmol/L) for 15 minutes before ischemia in
subgroups of sham and band (sham-HMA and band-HMA). Infusion was
continued during ischemia (same final concentration) and was
terminated on reperfusion.
NMR Spectroscopy
The 23Na and 31P NMR spectra were
obtained with a Bruker AM-360 spectrometer with a homebuilt
temperature-controlled switchable NMR probe, which could collect
spectra from both nuclei without retuning. Data collection alternated
automatically between the collection of 23Na (1 minute) and
31P (2 minutes) NMR spectra. The 23Na NMR
spectral acquisition parameters and the signal area
measurement methodology were as previously described.23
Gaussian multiplication of the 23Na free induction decays
was used for signal-to-noise noise improvement and (minimal) resolution
enhancement; the NMR1 GM subroutine was used
with parameters G1=0, G2=20, and G3=0.1 (NMR1
software, New Methods Research, Inc).
NMR-visible Na+i was quantified in the
experiments by comparison with spectra obtained after the experiment
from an NaCl solution contained within a heart-sized glass sphere.
However, for all protocols, Na+i was reported
as percent control to focus on changes in the
Na+i rather than absolute differences and to
reduce experimental variability resulting from quantification errors.
Also, the reporting of Na+i content requires
assumptions concerning the 23Na NMR visibility, which has
not been directly determined for these conditions. Comparison between
the experimental groups using percent control is valid because absolute
control values for sham and band (19.1±0.5 and 18.1±1.0 µmol NMR
visible Na+i per g dry wt, respectively) were
not significantly different. Also, no significant differences were
found between subgroups of sham or of band.
The 31P NMR spectral acquisition parameters,
plotting parameters, and signal area measurement
methodology were as previously described.23 Phosphorus
metabolites were quantified by comparing the signal areas with those
from the 100 mmol/L PPA standard solution in the left
ventricular balloon; linear regression was performed on
signal areas from several spectra obtained at the end of the experiment
after incremental balloon volume increases. For each experiment, a
fully relaxed spectrum, using a recycle time of 10 seconds, was
acquired before the control period. From comparison with the control
spectra, empirical saturation factors for the various resonances were
derived: 1.58, 1.40, and 1.17 for PPA, PCr, and ATP, respectively. Low
control Pi levels necessitated calculating a value (1.10)
from the reported spin-lattice relaxation time (T1) for
Pi in rat heart31 by using Equation 17 from
Becker et al.32 pHi was calculated from the
shift of the Pi resonance.33
Lactate Measurements
Lactate efflux (in micromoles per minute per gram dry weight)
was measured by analysis of the coronary effluent
(assay kit No. 826, Sigma Chemical Co). During ischemia, the
entire effluent was collected at 17-minute intervals, taking care to
remove coronary effluent remaining in the NMR tube by external
flushing. During reperfusion, the effluent was collected at 2, 3, 4, 5,
10, 15, 30, and 45 minutes of reperfusion.
Electrogram Measurements
Simultaneous electrogram and NMR measurements were
not possible because of the introduction of radiofrequency noise.
However, several sham (n=3) and band (n=3) hearts were perfused with
shift reagent perfusate exactly as described above without collecting
NMR data. Three bipolar plunge electrodes constructed of
polytetrafluoroethylene (Teflon)coated wire were placed in the
ventricular myocardium. By use of an Astromed
9500 multichannel recorder, multiple local electrograms were
simultaneously recorded from different positions on the
ventricles.
Statistics
Values were reported as mean±SEM. An NCSS software
package was used for statistical analysis. General linear
models ANOVA was generally used; paired t tests were also
used as indicated. Fishers exact test was used to compare the incidence
of VF between groups. Results were considered significant at
P<.05. To test VF predictability, the Number Cruncher
Statistical System (NCSS) discriminant analysis
routine was used as described.
 |
Results
|
|---|
Functional and Electrophysiological
Measurements
Fig 1

shows portions of typical functional traces
from two sham
hearts subjected to ischemia and reperfusion.
During early ischemia,
both hearts maintained contraction at
the paced heart rate at
reduced developed pressure. In the heart
depicted in the top
trace, diminished contractions continued steadily
throughout
ischemia; contraction amplitude was quickly restored
after reperfusion.
In contrast, the heart depicted in the lower trace
exhibited
abrupt contractile failure, which continued until reperfusion
despite
stimulation. Unlike the heart in the top trace,
diastolic tension
rapidly increased on reperfusion,
accompanied by chaotic oscillations;
it decreased markedly
on the restoration of contraction. These
patterns suggested
ischemia-induced VF.
18 Fig 2

shows
a local
electrogram from one of several electrodes placed on a sham
heart.
The recordings taken minutes before ischemic
contractile failure
show the typical synchronized electrical activity
of contracting
myocardium. Seconds before contractile
failure, the pressure
and electrogram recordings indicated the
presence of additional
contractions between the pacing stimuli. After
contractile failure,
the heart was not quiescent but indicated the
chaotic electrical
activity typical of VF, which was not synchronized
with that
recorded from the other electrodes (not shown).
Electrogram
recordings from each of the hearts exhibiting
contractile failure
(two of three sham hearts, three of three band
hearts) were
quite similar, with initiation of sustained VF beginning
at
the time of contractile failure. In each case, VF continued
into
reperfusion and terminated at, or shortly before, the return
of normal
contraction. Like the lower trace in Fig 1

, the pressure
traces
indicated abrupt contractile failure and recovery patterns
as well as
elevated diastolic tension and chaotic
oscillations
during early reperfusion; these were also the
typical patterns
for all of the hearts in the study that experienced
contractile
failure. This, combined with the electrogram data, strongly
suggests
that in this model of ischemia, contractile failure
during ischemia
and reperfusion is caused by VF.

View larger version (18K):
[in this window]
[in a new window]
|
Figure 1. Portions of functional traces indicating left
ventricular pressure are shown for two sham hearts (at
different chart recorder speeds). The traces indicate function
during control perfusion, the midischemic period, and early and
late reperfusion; the arrows indicate the onset of ischemia or
reperfusion.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Figure 2. Representative LVDP (top traces) and
local electrograms (lower traces) were recorded in
myocardium from a band heart during low-flow
ischemia and 2.5-Hz pacing at 10 minutes before contractile
failure (left), 20 seconds before contractile failure (middle), and 20
seconds after contractile failure (right).
|
|
The percentage of all untreated sham hearts (n=24, including those used
for NMR and electrogram measurements) exhibiting such contractile
failure/VF during the ischemic period was 50%, a proportion
significantly less than the 89% observed for untreated band hearts
(n=18, P<.01). The mean ischemia times at which
fibrillating sham (sham-VF) hearts and fibrillating band (band-VF)
hearts went into VF were 35.8±2.3 and 29.8±2.1 minutes, respectively.
Most interestingly, the preparations treated with HMA during
ischemia, sham-HMA and band-HMA groups, all continued
contracting throughout the protocol and did not exhibit VF,
representing significantly lower incidences of VF than were
observed in the untreated sham and band groups. This is
consistent with previous reports that
Na+-H+ inhibition reduces reperfusion
arrhythmias.23 34 The mean heart dry weights, body
weights, and heart dry weighttobody weight ratios were 0.213±0.004
g, 357±7 g, and 6.01±0.13x10-4, respectively,
for the sham group and 0.281±0.008 g (P<.0001 versus
sham), 320±10 g (P<.005 versus sham), and
8.92±0.28x10-4 (P<.0001 versus sham),
respectively, for the band group. The data clearly indicate the
development of substantial hypertrophy in band hearts.
There were no significant differences or different trends evident
between the sham or the band subgroups for these parameters
(data not shown). To eliminate from the study hearts from animals that
may have been banded ineffectively, band hearts were not included in
the study if the total heart wet weighttobody weight ratio was
lower than the mean value by more than 1 SD; only two of 29 band hearts
were eliminated from the study in this fashion.
Table 1
summarizes LVDP during (pre-HMA) control and end
reperfusion for all sham and band subgroups on which NMR measurements
were obtained, including untreated hearts that contracted throughout
ischemia (sham-C, n=11; band-C, n=2), HMA-treated hearts
(sham-HMA, n=6; band-HMA, n=9), and hearts exhibiting contractile
failure/VF (sham-VF, n=10; band-VF, n=13). As expected, the band hearts
had significantly higher ventricular pressures than did the
sham hearts because of hypertrophy of the
ventricular wall. No significant differences were found
between the sham subgroups or between the band subgroups in either
control or end reperfusion LVDP. During reperfusion, a complete
functional recovery was observed in all hearts, confirming that the VF
was ischemia-induced. However, the recovery for the sham- and
band-VF hearts was delayed compared with the sham- and band-C and -HMA
groups. Steady contraction in the range of 10 mm Hg LVDP was
maintained in all band- and sham-C and -HMA groups during
ischemia, with diastolic tension remaining
relatively stable throughout the protocol. In contrast, between early
and late ischemia in sham-VF, diastolic tension
increased from 3±1 to 14±1 mm Hg. On reperfusion,
diastolic tension markedly increased to 47±6 mm Hg (at 2
minutes reperfusion). The mean diastolic tension gradually
decreased over the next 10 minutes, although in individual experiments
the decreases were invariably abrupt and associated with the restart of
contraction. The band-VF group also showed increasing
diastolic tension during ischemia (increased from
4±1 to 22±5 mm Hg), which also sharply increased to 53±10 mm Hg at
2 minutes of reperfusion before returning to the control level. The
LVDP values at the end of preischemic HMA infusion for
sham-HMA and band-HMA were 89±15 and 159±9 mm Hg, respectively,
values that were virtually unchanged from the pre-HMA control values
reported in Table 1
.
View this table:
[in this window]
[in a new window]
|
Table 1. LVDP During Control Perfusion (Preceding HMA
Administration) and During End Reperfusion for Sham- and Band-C, -VF,
and -HMA Subgroups
|
|
NMR Measurements
Fig 3A
displays 23Na NMR spectra
obtained from a sham-C heart during control and at end
ischemia. Note that the Tm(DOTP)5- shift reagent
affords excellent resolution of the Na+i
resonance even in the presence of the large extracellular
Na+ resonance, derived largely from the coronary
effluent surrounding the preparation. The frequency of the
Na+i and extracellular Na+
resonances as well as the area of the extracellular Na+
resonance were extraordinarily stable throughout the experiments. The
balloon reference signal area was similarly stable, but its frequency
exhibited instability and heterogeneity upon the
introduction of ischemia. Macroscopic geometry considerations
make the bulk magnetic susceptibility shift component of the balloon
resonance sensitive to the vascular changes that alter the shift
reagent content of the surrounding tissue.35 The figure
indicates an increase in the Na+i resonance
during ischemia to 144% of control, as was typical for the
contracting hearts. In Fig 3B
, analogous 23Na NMR spectra
are shown from a band-VF heart. In contrast to the heart depicted in
Fig 3A
, the spectra indicate a substantial increase in
Na+i to 350% of control, revealing that in the
fibrillating heart, Na+i homeostasis was
significantly altered. Fig 4
shows the interleaved
31P NMR spectra from the same two hearts shown in Fig 3
and
reveals that the fibrillating band-VF heart also indicated
substantially more depletion of PCr, ATP, and accumulation of
Pi than the contracting sham-C heart.

View larger version (15K):
[in this window]
[in a new window]
|
Figure 3. A, 23Na NMR spectra obtained on a sham
heart in which contraction was maintained throughout ischemia
(sham-C), shown during control and at end ischemia. The unshifted
resonance at 0 ppm is from Na+i. The
resonance at 2.5 ppm is from Na+o,
shifted downfield with 4 mmol/L Tm(DOTP)5-. At 8 ppm is
the left ventricular balloon reference, also shifted with 4
mmol/L Tm(DOTP)5- (larger shift due to absence of
Ca2+). B, 23Na NMR spectra obtained from
a band-VF heart (fibrillating band) during control and at end
ischemia.
|
|

View larger version (15K):
[in this window]
[in a new window]
|
Figure 4. 31P NMR spectra from the same two hearts
shown in Fig 3 , obtained during control and at end ischemia. A, Sham-C
heart, with the intracellular resonances: Pi, PCR,
-, ß-, and -ATP, and the PPA reference from the left
ventricular balloon, as indicated. B, Analogous spectra
from the band-VF heart.
|
|
In Fig 5
, mean values of Na+i
and pHi are shown across time for the various experimental
groups. Consistent with the spectra in Fig 3
, the data indicate
that in the contracting groups Na+i increased
moderately during ischemia and then became relatively stable.
In contrast, Na+i increased to
300% of
control in the sham-VF and band-VF groups, a much greater increase
compared with their respective sham- and band-C and -HMA groups
(P<.005, end ischemia). Although the
pHi changes were not nearly as severe as are observed with
zero-flow ischemia models,23 the sham-VF and
band-VF groups also indicated greater decreases in pHi
compared with their respective sham- and band-C and -HMA contracting
groups (P<.05 at end ischemia, except for band-C). For the
sham-HMA and band-HMA groups, Na+i decreased
during the 15-minute preischemic loading period, decreasing
to 78±2% and 87±3% of the control value, respectively. Even during
early ischemia, Na+i in the HMA groups
was maintained at lower levels than in the VF groups. In the sham-HMA
group, HMA treatment attenuated Na+i
accumulation, even when compared with the sham-C group
(P<.05 versus sham-HMA at end ischemia). The
divergence of the cationic changes in the VF and contracting groups
became particularly marked during latter ischemia, when changes
in the VF groups accelerated. No differences were evident when
comparing sham groups with analogous band groups; the changes were all
remarkably similar. An essentially complete recovery of both
Na+i and pHi during reperfusion was
observed for all groups; at end reperfusion (pooled the final 10
minutes), Na+i in the band-VF group did remain
at
10% above control levels (P<.05). The HMA groups
tended to recover to levels below their respective control levels
(P<.05 for sham-HMA).

View larger version (36K):
[in this window]
[in a new window]
|
Figure 5. Mean values of Na+i (A) and
pHi (B) are shown across time during control,
ischemia, and reperfusion for sham-C, -VF, and -HMA groups.
Similarly, Na+i (C) and pHi (D) are
shown for the analogous band groups, with band-C only displayed at
-4-, 20-, 50-, and 110-minute time points for clarity of
presentation.
|
|
Fig 6
shows mean PCr, ATP, and Pi content
plotted across time for sham and band subgroups. There were no
significant differences in phosphorus metabolites between the sham or
the band subgroups during control conditions. However, the figure
indicates lower control levels of PCr in band compared with sham
groups. The PCr, ATP, and Pi for combined sham subgroups in
the control condition (before HMA) were as follows (µmol/g dry wt):
53.3±1.6, 29.2±1.0, and 1.9±0.5, respectively, and 39.8±2.0
(P<.0001 versus sham), 26.4±1.2 (P=.08 versus
sham), and 3.3±0.5 (P<.05 versus sham), respectively, for
combined band subgroups. During ischemia, greater PCr and ATP
depletion and Pi accumulation occurred in the sham-VF and
band-VF groups than in their respective sham- and band-C and -HMA
groups, particularly during latter ischemia (P<.05
at end ischemia). Deterioration of cellular energy in the sham-
or band-HMA and -C groups was moderate but not necessarily equal:
Pi accumulation was greater in the sham-HMA group than in
the sham-C group (P<.05 at end ischemia). In all
groups, PCr recovered completely during reperfusion. In contrast, ATP
remained significantly below control levels at end reperfusion (pooled
the final 10 minutes) in all groups and also was lower in VF groups
than in analogous contracting groups at that time (sham-VF versus
sham-C and sham-HMA, P<.005; band-VF versus band-HMA,
P<.05). In the VF groups, Pi remained
significantly above control levels at end reperfusion.

View larger version (35K):
[in this window]
[in a new window]
|
Figure 6. Mean values of PCr (A), ATP (B), and Pi
(C) are shown across time during control, ischemia, and
reperfusion for sham-C, -VF, and -HMA groups. Similarly, PCr (D), ATP
(E), and Pi (F) are indicated for the analogous band
groups, with band-C only displayed at -4-, 20-, 50-, and 110-minute
time points for clarity of presentation.
|
|
Fig 7
shows mean lactate efflux rates for sham and band
subgroups. Lactate efflux increased gradually throughout
ischemia to rather substantial levels, near 20 µmol/g dry wt
per minute. On reperfusion, lactate efflux increased transiently and
then rapidly decreased toward control levels. No significant
differences in lactate efflux were detected between any groups during
ischemia. However, during early reperfusion, lactate efflux
markedly increased for sham- and band-VF groups to levels much higher
than were observed in the sham- and band-C groups. There was also
evidence for elevated reperfusion lactate efflux in the HMA groups.
Calculation of total lactate efflux during the first 15 minutes of
reperfusion confirmed that reperfusion lactate efflux was greater in
the sham- and band-VF than in the sham- and band-C groups (µmol/g dry
wt): sham-VF, 135±25; sham-C, 53±13 (P=.012 versus
sham-VF); sham-HMA, 87±13; band-VF, 109±17; band-C, 28±19; and
band-HMA, 118±29. Both the combined sham- and band-VF groups
(P<.003) and the combined sham- and band-HMA groups
(P<.02) demonstrated greater total reperfusion lactate
efflux than the combined sham- and band-C groups.

View larger version (22K):
[in this window]
[in a new window]
|
Figure 7. A, Mean lactate efflux values are indicated across
time during control, ischemia, and reperfusion for sham-C, -VF,
and -HMA groups. Insets show detail of early reperfusion period.
*P<.05 vs sham-C. B, Mean lactate efflux values for
analogous band groups. *P<.05 vs band-HMA.
|
|
Fig 8
shows sham-VF and band-VF
Na+i and pHi data obtained during
the ischemic period only that are plotted versus the time from
VF. Ischemia times vary at the onset of VF, so the observed
changes require careful interpretation. However, the plots reveal that
rapid Na+i and pHi changes started
to occur at the onset of VF. The abrupt change in the slopes indicates
that exactly at that time, net Na+ influx dramatically
increased and resulted in levels near 300% of control within a few
minutes. Panels B and D in Fig 8
indicate that these rapid changes were
paralleled by decreases in pHi, which decreased
from values near 7.0 before VF to values near 6.8 after 10 minutes of
VF. Table 2
indicates values of the
metabolic parameters 3 minutes before and 3
minutes after the onset of VF and reveals that rapid changes were also
occurring in energetic parameters. Although only 6 minutes
separated these time points, all of the cationic and energetic
parameters were found to be significantly different (paired
t test).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 8. Mean values of Na+i
(A) and pHi (B) are shown during ischemia for the
sham-VF group plotted vs the time from VF, with zero time at VF
initiation. For comparison, data from the sham-C and -HMA groups
obtained during latter ischemia are plotted vs ischemia
duration, referenced to the average time of VF initiation in the
sham-VF group as the zero time point. Similarly,
Na+i (C) and pHi (D) are indicated
for the band-VF group plotted vs the time from VF. Data from the band-C
and -HMA groups are also shown, with zero time at the average time of
VF initiation in the band-VF group.
|
|
In addition to showing Na+i and pHi
data versus time from VF, Fig 8
also indicates data from the
contracting groups (sham- or band-C and -HMA) obtained during the
latter ischemic period; the data were referenced to
ischemia duration, but with the average time of VF initiation
in the analogous VF group taken as the zero time point. The data
illustrate the relative stability of Na+i and
pHi during latter ischemia in the contracting
groups. Comparison with VF groups clearly indicates that substantial
alteration of cation homeostasis occurs after VF and is not due to
ischemia alone but is largely due to the presence of sustained
ischemia-induced VF. However, the figure also suggests that
although not nearly as severe, alteration in cationic homeostasis
before the onset of VF in the VF groups was greater than that occurring
during ischemia in the contracting groups. The
Na+i levels 3 minutes before VF initiation in
the sham-VF and band-VF groups (see Table 2
) were higher than those in
their respective sham- and band-C and -HMA groups at 3 minutes before
the average time of VF (P<.001, excluding band-C). The
Na+i level for both VF groups was at 160% of
control. In contrast, it was 129±3% and 116±3% for sham-C and -HMA
groups, respectively, and 126±18% and 120±5% for band-C and -HMA
groups, respectively, indicating a Na+i
accumulation equal to or less than half of that observed in the VF
groups. A similar comparison with pHi indicated small but
measurable differences (P<.05, excluding band-C).
In addition to comparing data referenced to VF onset with that
referenced to ischemia duration, a rigorous analysis
was done comparing data obtained at the same duration of
ischemia. The 20-minute time point was chosen because it is a
substantial period of ischemia, the metabolic
parameters in the contracting groups were stabilizing, and
importantly, none of the hearts were in VF. Although the 20-minute time
point long preceded the average time of VF in both VF groups,
differences in certain metabolic parameters
were apparent between the VF and contracting groups. Notably, although
Na+i at 20 minutes did not approach the extreme
levels occurring after VF, Na+i was
significantly greater at 20 minutes in the sham-VF group (144±4%)
than in both the sham-C and sham-HMA groups (128±4% and 117±3%,
respectively; P<.005). Similarly, the mean
Na+i level in the band-VF group (148±3%)
increased significantly more at 20 minutes of ischemia than in
the band-C group (122±19%; P<.05) and the band-HMA group
(118±4%; P<.005). Consistent with Fig 8
, the data
indicate that Na+i accumulation in the
contracting groups was approximately half of that observed in the VF
groups. In the sham-VF group, ATP was significantly lower and the
Pi was higher than in the sham-C group. Statistical
differences in phosphorus metabolites were not detected between band-VF
and band-C groups. Interestingly, there were no significant differences
in any phosphorus metabolites detected between the VF and HMA subgroups
in both sham and band groups. Consistent with this observation
was that PCr and ATP were significantly lower and Pi was
higher in the sham-HMA group than in the sham-C group at the 20-minute
time point. Hence, the data suggest a relatively specific attenuation
of Na+i accumulation during ischemia in
band and sham groups with Na+-H+ exchange
inhibition; HMA did not offer any measurable protection from
high-energy phosphate depletion.
Data at the 20-minute ischemia time point were analyzed
further by discriminant analysis to determine the ability to
predict VF from the metabolic variables. This
statistical technique simultaneously considers a profile of
variables, thus improving predictive power by considering
variable interaction and patterns. The analysis models an
equation, which calculates the probability of a certain experimental
outcome (VF), based on the variables. Table 3
summarizes the results of this analysis. The
parameter PR is the percent improvement in classification
accuracy over random classification and is lower than (or equal for
PR=100%) the absolute classification accuracy; PR of 80% indicates
that 90% of the experiments were correctly classified. The F-PROB
values indicate the significance of the variable in the prediction,
with lower values indicating higher significance (range, 0 to 1). Table 3
summarizes VF prediction analyses using
Pi, PCr, ATP, pHi, and
Na+i (at 20 minutes of ischemia) with
three different group combinations: sham-VF versus sham-C, sham-VF
versus sham-HMA, and band-VF versus band-HMA. An analysis of
band-VF versus band-C alone was not possible because of the low
experimental number of band-C. Combined band and sham analyses
were not performed because they started with inherently different
energy patterns at control. The PR values indicated in the table
demonstrate excellent VF prediction from the metabolic
variables, and the F-PROB parameters indicate that
Na+i is clearly the most powerful VF predictor.
This is especially true for the analyses involving HMA groups,
which indicate 100% predictive accuracy and very low F-PROB values for
Na+i. The analyses were repeated after
removing Na+i or both
Na+i and pHi from consideration
(not shown). Interestingly, for the sham-VF versus sham-C groups,
prediction accuracy did not decrease; PR remained at
80%, and
Pi became the most significant variable. When VF
prediction was tested from individual variables alone,
Na+i gave the lowest F-PROB values, but
Na+i, Pi, and ATP
each still succeeded in predicting VF with a PR of 60% (other
variables,
30%). Contrasting results were obtained with sham-VF
versus sham-HMA and band-VF versus band-HMA groups. Removal of
Na+i from consideration resulted in low
prediction accuracy (PR,
30%). Only Na+i
could predict VF by itself, with by far the lowest F-PROB values and
with PR values of 88% and 62% for sham and band groups, respectively
(
30% for the other variables). Analyses that tested VF
prediction within all three sham groups and within all three band
groups were also performed. In these cases, prediction accuracy was
still high, and under all conditions, Na+i was
the only predictive variable; the inclusion of sham-HMA apparently
reduced the prediction significance of the energy variables within
the sham subgroups.
View this table:
[in this window]
[in a new window]
|
Table 3. F-PROB and PR Values From the Discriminant
Analysis Indicating the Predictability of VF From the
Metabolic Variables
|
|
In addition to using the metabolic parameters
at 20 minutes of ischemia, extensive discriminant
analyses were performed using the control data. Little
predictive accuracy was found at that time, and PR remained
20% in
all cases. Additionally, dry weight, the dry weighttobody weight
ratio, and control LVDP were found to be poor predictors of VF within
sham or band groups. No combination of these variables with the
metabolic variables resulted in increased predictive
accuracy.
In comparing the functional and Na+i
reperfusion data in the VF groups, a significant correlation
(P<.0001) was found between the reperfusion time required
to reestablish paced contractions with an LVDP of
10 mm Hg
(Tfunc) and that required for Na+i
to decrease below 160% of control (TNa+), the
mean level at which VF was initiated (see Table 2
) during
ischemia. Linear regression was used to fit the following
function (in minutes):
Tfunc=0.94 · TNa++0.44;
R2=.62. Also of note is that the mean values for
these parameters were essentially identical in both VF
groups: mean Tfunc and mean TNa+
were 9.0±1.0 and 8.8±0.7 minutes, respectively, for the sham-VF group
and 7.6±1.3 and 8.0±1.2 minutes, respectively, for the band-VF group.
Consistent with this, an examination of the
Na+i levels in each heart using the
23Na NMR spectrum closest to the time of contractile
recovery indicated mean values of 148±8% and 159±10% for sham-VF
and band-VF groups, respectively.
 |
Discussion
|
|---|
Metabolic Alterations Preceding VF
Table 2

shows that the metabolic states immediately
preceding
VF in sham- and band-VF groups were strikingly similar,
despite
the different control energy reserve in those groups. Fig 8

indicates
that this pre-VF metabolic state, and in
particular Na
+i homeostasis,
was different from
that observed in the analogous contracting
groups during latter
ischemia. A comparison of all parameters
at 20
minutes of ischemia (preceding all VF) revealed that although
relatively
moderate, the increases in Na
+i in
both sham- and band-VF groups
were consistently greater than
those occurring in their respective
sham- and band-C and -HMA groups.
However, significant differences
in pH
i were not detected.
Differences in the cellular energy
state were detected between sham-VF
and sham-C groups but not
in the three other comparisons between VF and
contracting groups.
The observations in the untreated sham subgroups
provide evidence
that the metabolic changes resulting in
ischemia-induced VF
could involve both
Na
+i and cellular energy. However, the only
measured
metabolic factor that was consistently
different between the
VF groups and virtually all the contracting
groups was that
of the Na
+i level, suggesting
that its involvement may be more
direct. Normally, the
Na
+i level could well be coupled to the
cellular
energy state,
36 but in hearts exposed to HMA,
Na
+i accumulation
was attenuated irrespective
of the pattern of energetic deterioration.
Exemplifying this,
phosphorus metabolite changes in the sham-HMA
group at 20 minutes of
ischemia were similar to those in the
sham-VF group.
Nevertheless, Na
+i accumulation was attenuated
and
VF was prevented. In addition, the discriminant analysis
indicated
that the Na
+i level before VF was
invariably the most predictive
metabolic variable and
was in fact the only consistent VF predictor
between the VF and
contracting groups. The retention of predictive
accuracy when
Na
+i and pH
i were removed from the
analysis with
the untreated sham groups did suggest that a
different pattern
of phosphorus metabolites existed in those two
subgroups. However,
VF prediction was excellent between analogous VF
and HMA groups,
and it depended solely on
Na
+i.
Prevention of VF via HMA was not likely to result from effects
unrelated to Na+-H+ inhibition. HMA is a
specific inhibitor, with a Ki (0.16
µmol/L) >500 times lower than that of amiloride.37
Unlike with amiloride, experiments using HMA can employ an effective
inhibitory concentration that is an order of magnitude
lower than the Ki reported for
Na+-Ca2+ exchange.37 The
lack of functional effects after 15 minutes of preischemic
perfusion with HMA argues against nonspecific effects, especially in
regard to direct effects on Ca2+i
handling. The lack of an effect on pHi during
ischemia is consistent with a previous report from our
laboratory23 and with other studies.25 38 39 40
This observation is likely to be related to the activity of alternative
H+ extrusion mechanisms such as lactate-H+
cotransport and CO2 efflux.40
Consistent with a previous study,23
Na+-H+ exchange inhibition succeeded in
reducing Na+i levels during low-flow
ischemia. This reduction was associated with prevention of VF.
Although a cause-and-effect relation between VF initiation and
increased Na+i cannot be conclusively
determined, such a role would be consistent with the data and
with recent reports indicating involvement of
Ca2+i levels.5 6 13 16
Electrogenic Na+-Ca2+ exchange is the
primary sarcolemmal Ca2+ extrusion mechanism, and its
activity exhibits a steep dependence on the Na+
gradient.28 This is imposed by the 3:1 exchange
stoichiometry, which at exchange equilibrium would theoretically
magnify Na+i changes to the third power in
terms of responding Ca2+i changes.
These considerations make it likely that
Ca2+i would increase in response to an
increase in Na+i. Possible mechanisms by which
increased Ca2+i may initiate VF include
induction of triggered activity in the form of afterdepolarizations,
which often precede VF.5 6 Afterdepolarizations may be
triggered by a "transient inward current," reportedly linked to
excess Ca2+i
accumulation.8 9 10 13 Ca2+i
accumulation can induce oscillations in
Ca2+i via spontaneous sarcoplasmic
reticulum Ca2+ release7 and thus
potentiate the inward current by activation of electrogenic
Na+-Ca2+ exchange11 or
nonspecific cation channels.12 The reported antiarrhythmic
effect of inhibiting sarcoplasmic reticulum function with ryanodine
supports such a role for Ca2+i
oscillations.13 16 41 In support of such a
role for Ca2+i overload in
ischemia-induced VF, increases in
Ca2+i have been well documented in
myocardium exposed to zero-flow ischemia or
hypoxia.20 21 22 25 26 27 Low-flow ischemia is
more complex, since with mild coronary flow reductions
insufficient to cause cellular energy depletion (flow, >50% of
control), systolic Ca2+i reportedly
decreases; this could be an important mechanism to downregulate
function and energy consumption.42 However, as flow
reductions become severe and approach zero flow,
Ca2+i increases are likely. Using indo
1 and a 10% flow glucose-perfused rat heart model like the one in the
present study, Camacho et al19 reported increases in
diastolic and systolic
Ca2+i levels in contracting hearts.
Also, the reported high-energy phosphate and pHi changes
were very consistent with those in the present study. The
40% increase in diastolic
Ca2+i reported during 10%
flow19 is similar to the increase reported to precede
spontaneous VF initiated with partial Na+-K+
ATPase inhibition in the ferret heart16 ; it is also
consistent with changes reported for a rat heart before
spontaneous VF.15 Importantly, these moderate pre-VF
elevations of Ca2+i are in a range
consistent with the magnitude of the pre-VF
Na+i changes observed in the present study,
in terms of likely effects from Na+-Ca2+
coupling and exchange.28
In the VF groups, remarkably few arrhythmias were observed
during early ischemia, but they were usually observed before
the onset of VF. It was found that the time duration between the point
the arrhythmias started and that of VF initiation (mean,
8.1±1.4 minutes) correlated significantly (P<.0001) with
the Na+i levels 3 minutes before the onset of
VF in individual hearts in the combined sham-VF and band-VF groups.
Linear regression was used to fit the following function:
arrhythmia duration=26 · Na+VF-34
(R2=.56), where Na+VF is
the Na+i level 3 minutes before the onset of
VF. This correlation is consistent with the concept that
Na+i plays a causal role in the induction of
arrhythmias that precede and precipitate
VF.1 5 6 13 16 Notably, however, Na+ influx
during ischemia is not restricted to
Na+-H+ exchange, because continued
depolarization and contraction ensures a contribution via
voltage-activated Na+ channels. The magnitude
depends on conditions such as the pacing rate, and the presence of
ventricular extrasystoles could potentially accelerate
Na+i accumulation itself. In this context, it
is important to note that the 20-minute ischemia time point not
only preceded all VF, but in sham-VF, it also preceded the development
of all arrhythmias in most cases. When the one exception was
excluded, the remaining (n=9) sham-VF hearts still exhibited higher
Na+i at 20 minutes than did sham-C
(P=.01) and sham-HMA (P<.0001) hearts.
Consistent with the effects observed with
Na+-H+ exchange inhibition, this suggests that
the excess Na+i accumulation preceding VF is
related to more than simply the presence of extrasystoles and is likely
to be more than just a marker for the arrhythmias that lead to
VF. A more interactive role for Na+i would be
consistent with the data.
Metabolic Alterations After VF
The Na+i versus time from VF data shown in
Fig 8
indicate that at a time coinciding with VF initiation, the slopes
changed by an order of magnitude. This indicates a dramatic increase in
net Na+ influx to rates far exceeding those normally
observed during zero-flow ischemia.23 This is
consistent with reports that ventricular cells are
rapidly excited at the onset of VF, with substantial fast channel
(voltage-activated Na+ channel) activity occurring
during its early stages.43 44 The
Na+i increases and associated alterations of
Na+-Ca2+ exchange28 are
more than adequate to explain the fivefold increases in
Ca2+i reported by Koretsune and
Marban,14 which occurred within 5 to 10 minutes of VF
initiation. Other studies have also reported extraordinary increases in
Ca2+i after VF, occurring on the same
time scale as the Na+i changes in the
present study,15 16 suggesting that
Na+i is an important factor to be considered in
the acceleration and maintenance of the
Ca2+i overload and hence VF itself. The
cellular energy and pHi changes may also be accelerated by
the Na+i overload. Increased
Na+i increases energy demand by stimulating
Na+,K+-ATPase activity.45
Accompanying increases in Ca2+i would
also increase energy demand via contractile apparatus
activation, consistent with the post-VF increase in
diastolic tension observed in the present study. The
post-VF pHi decreases in the present study may also be
related to Ca2+i, because
increases in Ca2+i reportedly depress
pHi.46 Severe Ca2+ overload
can result in mitochondrial Ca2+ accumulation and
thus decrease energy production, which is already slowed during
low-flow ischemia.47 Such an effect could promote
cycles of further metabolic deterioration by slowing
Na+,K+-ATPase activity and thus
increasing Na+i further. Consistent
with this, both increased energy utilization and decreased energy
production have been reported during VF initiated via partial
Na+,K+-ATPase inhibition.48
Severe Ca2+i overload and cellular
energy depletion also occurred.16 18 48 With VF initiated
with electrical burst pacing, Ca2+i
overload is of lesser severity, minimal energy depletion occurs, and in
contrast to the other model, spontaneous defibrillation often
occurs.14 16 48 With either model, effective
defibrillation occurs with low Ca2+
perfusion.41 In combination with the present findings,
these results are consistent with the hypothesis that VF is
maintained, in part, by an inability to regain control of ion
homeostasis because of compromised energy production and/or
Na+,K+-ATPase activity.
The general association of Na+i accumulation
and VF is consistent with a previous study that investigated
hypoxia-induced contractile failure in the perfused rat
heart.49 However, the previous report implied that most of
the increase in Na+i occurred well before the
onset of contractile failure/VF. In contrast, the present study
indicates that severe Na+i overload occurred
only after VF initiation, a pattern that tracks reported
Ca2+i changes with spontaneous
VF.15 16 A large Na+i increase
preceding VF might then imply a decoupling of the
Na+i and Ca2+i
time courses. These apparent differences may be related to the
different hypoxic and ischemic VF models but may also be
related to the difficulty of direct data comparison. Different
23Na NMR shift reagent methodology was used, and the
previous report did not plot data versus the time from VF. The
Na+i increase before the mean time of VF may
have been largely attributable to hearts already in VF, as is clearly
the case in the present study (see Figs 5
and 8
, and mean times of
VF initiation). Although in the previous study the
parameters curve-fitted to the pre-VF
Na+i data indicated a divergent time course,
the magnitude of the pre-VF Na+i changes was
not indicated.
Functional and Metabolic Alterations During
Reperfusion
Functional recovery was delayed for the VF groups, and end
reperfusion ATP was also lower compared with the contracting groups,
indicating greater metabolic injury. However, a complete
reperfusion functional recovery was observed in all groups, which is
consistent with other studies using low-flow ischemia
in perfused rat hearts supplied with glucose.23 27 50 That
the restart of contraction during reperfusion coincided closely in time
with VF termination was strongly suggested by the functional and
electrogram data. Hence, the observed correlation between the
reperfusion recovery times for Na+i
(TNa+) and function (Tfunc), as well as
the association of VF initiation during ischemia, and
termination during reperfusion with a similar
Na+i elevation, are consistent with a
role for Na+i in VF initiation and
maintenance. The data suggest that the recovery of
Na+i and Ca2+i
levels during reperfusion, enabled by the reactivation of energy
production and Na+,K+-ATPase
activity, is likely to be an important factor in the termination of VF
during reperfusion. This would be consistent with observations
in hearts that defibrillated spontaneously16 or with
lidocaine infusion14 15 ;
Ca2+i levels were observed to rapidly
approach control levels before or at the time of conversion to sinus
rhythm.
In the present study, a stimulation in reperfusion lactate efflux
was observed in sham- and band-VF compared with sham- and band-C
groups. This could be related to the greater ion imbalance in the VF
groups, given the reported role for glycolytic energy
production in ion homeostasis51 and reperfusion
Ca2+i recovery.52
Alternatively, the observations could to some degree be related to the
occurrence of poorly perfused regions in the VF hearts, perhaps related
to the gradual increases in diastolic tension/left
ventricular balloon pressure that occurred after VF.
Notably, however, these increases were relatively moderate, and the
high ischemic flow rates maintained in this
crystalloid-perfused low-flow model should ensure a minimum of vascular
washout throughout the tissue. Also, the pHi-sensitive
Pi resonance frequency normally indicates the presence of
regional infarcts or perfusion heterogeneity by
indicating multiple shift (pHi) components53 ;
this was not observed in the experiments at any time, and all hearts
exhibited an excellent functional recovery. This suggests that tissue
perfusion and the various metabolic parameters
are not likely to vary to any great extent across the preparation.
Increased Susceptibility of Hypertrophied Hearts to
VF
The increased susceptibility of the band hearts to
ischemia-induced VF is consistent with previous
reports,2 3 but the present study is the first to
document increased VF in hypertrophied myocardium in a
globally ischemic model that normalized vascular differences by
using the same ischemic flow per gram heart weight.
Consistent with other studies in normal and hypertrophied rat
heart models,2 3 heart weight parameters were
not consistently associated with VF incidence. Band hearts were
large, but neither the dry weight nor dry weighttobody weight ratio
differed significantly between subgroups of sham or band or were
predictive of VF within sham or band. Band hearts did have a lower
high-energy phosphate reserve compared with sham hearts, the origin of
which is potentially complex. In the context of the similarity of the
ischemic lactate production and identical flow/oxygen
delivery per gram tissue, the altered energy reserve could increase the
probability of band hearts reaching a critical energy-depleted
metabolic state during ischemia, sufficient to
permit excess cation accumulation. However, control levels of
phosphorus metabolites were similar between subgroups of sham or band
and were not predictive of VF within sham or band. In some studies,
reduced Na+,K+-ATPase activity in models
of myocardial hypertrophy has been
reported,54 55 although not in the aortic-banded
models.56 The present study contains no evidence for a
difference in inherent Na+ efflux capacity in band hearts.
Also, the present study cannot address the possibility that altered
electrophysiological parameters could
play a role in increased VF susceptibility in band
hearts.4
In summary, the present study demonstrated that initiation of
ischemia-induced VF was consistently preceded by a
moderate degree of excess Na+i
accumulation, the prevention of which also prevented VF. This
deterioration in Na+i homeostasis may be
coupled with the cellular energy state under normal conditions.
However, increased cellular energy depletion preceding VF was not
consistently observed. The present study is
consistent with a causal role for excess
Na+i accumulation in VF initiation.
Furthermore, the severe Na+i overload that
progressed rapidly after VF initiation strongly argues an important
role for Na+i in VF maintenance and the
associated deterioration of cellular energy. The association between
Na+i and VF was further strengthened by a
correlation between the reperfusion Na+i and
contractile recoveries. Given the likely coupling of
Na+i and Ca2+i
homeostasis and the previous reports linking
Ca2+i and VF, the present study
provides new and important information regarding the
metabolic deterioration leading to and sustaining
ischemia-induced VF.
 |
Selected Abbreviations and Acronyms
|
|---|
| HMA |
= |
5-(N,N-hexamethylene)-amiloride |
| LVDP |
= |
left ventricular developed pressure |
| NMR |
= |
nuclear magnetic resonance |
| PCr |
= |
phosphocreatine |
| Pi |
= |
inorganic phosphate |
| PPA |
= |
phenylphosphonic acid |
| Tm(DOTP)5- |
= |
thulium 1,4,7,10- |
|
|
| tetraazacyclododecane-N,N',N'',N'''- |
|
| tetramethylenephosphonate |
|
| VF |
= |
ventricular fibrillation |
|
 |
Acknowledgments
|
|---|
Dr Pike is an Established Investigator of the American Heart
Association.
We thank Dr Michael Hardin and Brett Thorn for valuable
advice
concerning the statistical analysis, Rebecca Lynn for
secretarial
assistance, and Marla Scogin for assistance with
graphics.
Received February 17, 1995;
accepted April 21, 1995.
 |
References
|
|---|
-
Brandenburg RO.
Cardiomyopathies and their role in sudden
death. J Am Coll Cardiol. 1985;5:185B-189B.
-
Kohya T, Kimura S, Myerburg RJ, Basset AL.
Susceptibility of hypertrophied rat hearts to
ventricular fibrillation during acute
ischemia. J Mol Cell Cardiol. 1988;20:159-168. [Medline]
[Order article via Infotrieve]
-
Robertson E, Hof RP, Zierhut W. Effect of
hypertrophy induced by pressure overload or volume overload
on reperfusion induced arrhythmias in anaesthetized
rats. Cardiovasc Res. 1993;27:515-519. [Abstract/Free Full Text]
-
Kowey PR, Friehling TD, Sewter J, Wu Y, Sokil A, Paul
J, Nocella J. Electrophysiological effects
of left ventricular hypertrophy: effect of
calcium and potassium channel blockade.
Circulation. 1991;83:2067-2075. [Abstract/Free Full Text]
-
Wit AL, Rosen MR. Afterdepolarization and
triggered activity. In: Fozzard HA, Haber E, Jennings RB, Katz
AM, Morgan HE, eds. The Heart and Cardiovascular
System. New York, NY: Raven Press Publishers; 1986:1449-1490.
-
Clusin WT, Buchbinder M, Harrison DC. Calcium
overload, `injury current,' and early ischaemic cardiac
arrhythmias: a direct connection. Lancet. 1983;1:272-273. [Medline]
[Order article via Infotrieve]
-
Orchard CH, Eisner DA, Allen DG.
Oscillations of intracellular
Ca2+ in mammalian cardiac muscle.
Nature. 1983;304:735-738. [Medline]
[Order article via Infotrieve]
-
Lederer WJ, Tsien RW. Transient inward current
underlying arrhythmogenic effects of cardiotonic steroids in Purkinje
fibers. J Physiol (Lond). 1976;263:73-100. [Abstract/Free Full Text]
-
Kass RS, Lederer WJ, Tsien RW, Weingart R. Role
of calcium ions in transient inward currents and aftercontractions
induced by strophanthidin in cardiac purkinje fibers. J
Physiol (Lond). 1978;281:187-208. [Abstract/Free Full Text]
-
Kass RS, Tsien RW, Weingart R. Ionic basis of
transient inward current induced by strophanthidin in cardiac Purkinje
fibers. J Physiol (Lond). 1978;281:209-226. [Abstract/Free Full Text]
-
Fedida D, Noble D, Rankin AC, Spindler AJ. The
arrhythmogenic transient inward current
iT1, and related contraction in isolated
guinea-pig ventricular myocytes. J
Physiol (Lond). 1987;392:523-542. [Abstract/Free Full Text]
-
Colquhoun D, Neher E, Reuter H, Stevens CF.
Inward current channels activated by intracellular Ca in
cultured cells. Nature. 1981;294:752-754. [Medline]
[Order article via Infotrieve]
-
Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L,
Willerson JT, Buja LM. Intracellular calcium transients and
arrhythmia in isolated heart cells.
Circ Res. 1991;69:810-819. [Abstract/Free Full Text]
-
Koretsune Y, Marban E. Cell calcium in the
pathophysiology of ventricular fibrillation and in the
pathogenesis of postarrhythmic contractile dysfunction.
Circulation. 1989;80:369-379. [Abstract/Free Full Text]
-
Stefenelli T, Wikman-Coffelt J, Shao T, Wu ST, Parmley
WW. Intracellular calcium during pacing-induced
ventricular fibrillation. J
Electrocardiol. 1992;25:221-228. [Medline]
[Order article via Infotrieve]
-
Kihara Y, Morgan JP. Intracellular calcium and
ventricular fibrillation: studies in the aequorin-loaded
isovolumic ferret heart. Circ Res. 1991;68:1378-1389. [Abstract/Free Full Text]
-
Grover FL, Fewel JG, Ghidoni JJ, Norton JB, Arom KV,
Trinkle JK. Effects of ventricular fibrillation on
coronary blood flow and myocardial
metabolism. J Thorac Cardiovasc
Surg. 1977;73:616-624. [Abstract]
-
Kusuoka H, Jacobus WE, Marban E. Calcium
oscillations in digitalis-induced ventricular
fibrillation: pathogenic role and metabolic consequences in
isolated ferret hearts. Circ Res. 1988;62:609-619. [Abstract/Free Full Text]
-
Camacho SA, Figueredo VM, Brandes R, Weiner MW.
Ca2+ dependent fluorescence
transients and phosphate metabolism during low-flow
ischemia in rat hearts. Am J Physiol. 1993;265:H114-H122. [Abstract/Free Full Text]
-
Marban E, Kitakaze M, Koretsune Y, Yue DT, Chacko VP,
Pike MM. Quantification of Ca2+i
in perfused hearts: critical evaluation of the 5F-BAPTA and nuclear
magnetic resonance method as applied to the study of ischemia
and reperfusion. Circ Res. 1990;66:1255-1267. [Abstract/Free Full Text]
-
Kihara Y, Grossman W, Morgan JP. Direct
measurement of changes in intracellular calcium transients during
hypoxia, ischemia, and reperfusion of the intact
mammalian heart. Circ Res. 1989;65(suppl
4):1029-1044.
-
Lee H, Mohabir R, Smith N, Franz M, Clusin W.
Effect of ischemia on calcium-dependent
fluorescence transients in rabbit hearts containing indo 1
correlation with monophasic action potentials and contraction.
Circulation. 1988;78:1047-1059. [Abstract/Free Full Text]
-
Pike MM, Luo CS, Clark MD, Kirk KA, Kitakaze M, Madden
MC, Cragoe EJ Jr, Pohost GM. NMR measurements of Na+
and cellular energy in the ischemic rat heart: role of
Na+/H+ exchange. Am J
Physiol. 1993;265:H2017-H2026.